Cargando…
Compound C Inhibits Renca Renal Epithelial Carcinoma Growth in Syngeneic Mouse Models by Blocking Cell Cycle Progression, Adhesion and Invasion
Compound C (CompC), an inhibitor of AMP-activated protein kinase, reduces the viability of various renal carcinoma cells. The molecular mechanism underlying anti-proliferative effect was investigated by flow cytometry and western blot analysis in Renca cells. Its effect on the growth of Renca xenogr...
Autores principales: | Lee, Myungyeon, Ham, Na Yeon, Hwang, Chi Yeon, Jang, Jiwon, Lee, Boram, Jeong, Joo-Won, Kang, Insug, Yeo, Eui-Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456023/ https://www.ncbi.nlm.nih.gov/pubmed/36077072 http://dx.doi.org/10.3390/ijms23179675 |
Ejemplares similares
-
Compound C Inhibits B16-F1 Tumor Growth in a Syngeneic Mouse Model via the Blockage of Cell Cycle Progression and Angiogenesis
por: Lee, Yun Taek, et al.
Publicado: (2019) -
Renca : folklore puntano.
Publicado: (1958) -
Intratumoral submicron particle docetaxel inhibits syngeneic Renca renal cancer growth and increases CD4+, CD8+, and Treg levels in peripheral blood
por: Maulhardt, Holly A., et al.
Publicado: (2020) -
Trafficking of activated lymphocytes into the RENCA tumour microcirculation in vivo in mice.
por: Brown, N. J., et al.
Publicado: (1997) -
Foxp3 Expression in Macrophages Associated with RENCA Tumors in Mice
por: Devaud, Christel, et al.
Publicado: (2014)